Enovis said it has entered into a binding offer to acquire eCential Robotics, a developer of surgical robotics.
Under the terms of the agreement, Enovis will acquire eCential Robotics for an upfront enterprise value of €155 million, which corresponds to cash consideration of approximately €176 million to be paid to eCential Robotics’ shareholders at closing, plus up to €35 million in contingent consideration payable upon the achievement of certain milestones. The transaction is expected to close by year-end 2026, subject to regulatory approvals.
eCential Robotics has developed a modular platform designed to advance the next generation of robotic-assisted surgery. The company's expertise in robotics engineering, software development, and surgical automation enhances Enovis' existing technology portfolio while adding capabilities that meaningfully accelerate Enovis’ robotic innovation roadmap.
“This acquisition is a significant milestone and reflects our disciplined approach to bringing externally developed innovation into Enovis. The eCential Robotics team brings exceptional engineering talent, intellectual property and a proven track record of bringing innovative robotic solutions to market. Their expertise will serve as the bedrock of our robotics strategy and enable Enovis to win in surgical enabling technology,” said Enovis CEO Damien McDonald in a statement. “eCential Robotics’ robotics platform is a natural complement to our ARVIS Augmented Reality System and will give surgeons a broader set of robotic solutions, aiming to improve precision, streamline workflows in the operating room and deliver better outcomes for patients.”
